Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
Clin Mol Hepatol. 2017;23(4):316-322. Published online 2017 Aug 22 DOI: https://doi.org/10.3350/cmh.2016.0087
Citations to this article as recorded by
Use of sofosbuvir in chronic kidney disease: Is it necessary?
Tae Seop Lim, Sang Hoon Ahn
Clinical and Molecular Hepatology.2017; 23(4): 308. CrossRef